Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Using Machine Learning for Identifying and Classifying Patient Groups

Posted on August 14th, 2017 by

To maximize value to payers, patients, and practitioners, pharma R&D wants to ensure that new medicines are given to the right patient, at the right time and at the right dose. To do this appropriately, we need ways to classify or diagnose patient groups.

Continue reading “Using Machine Learning for Identifying and Classifying Patient Groups” »

Delivering the Right Therapy to the Right Patient with ADCs

Posted on August 11th, 2017 by

One of the most powerful tools in the fight against cancer has become the patient’s very own immune system. Among the many approaches that researchers are exploring is the use of antibody-drug conjugates (ADCs) Continue reading “Delivering the Right Therapy to the Right Patient with ADCs” »

The Eternal Triangle of Quality, Speed, and Cost

Posted on August 7th, 2017 by

triangle-869123_640
A designer colleague once described to me the key issue involved in many of their creative design projects. It is finding the best balance between quality, speed, and cost. From a buyer perspective, we desire high quality, rapid delivery, and low cost. Continue reading “The Eternal Triangle of Quality, Speed, and Cost” »

A New Innovative Approach: Application of Digital Healthcare

Posted on August 4th, 2017 by

Just last week, US FDA Commissioner Dr. Scott Gottlieb published a blog on the FDA web site that talks about new policies the FDA is going to be acting upon. These new policies are designed to empower the consumer to act on his own and allow ‘digital healthcare’ technologies to help promote better health. Continue reading “A New Innovative Approach: Application of Digital Healthcare” »

  1. 1
  2. 2
  3. 3
  4. 43